These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 26257774)

  • 1. Dose-dependent effects of mTOR inhibition on weight and mitochondrial disease in mice.
    Johnson SC; Yanos ME; Bitto A; Castanza A; Gagnidze A; Gonzalez B; Gupta K; Hui J; Jarvie C; Johnson BM; Letexier N; McCanta L; Sangesland M; Tamis O; Uhde L; Van Den Ende A; Rabinovitch PS; Suh Y; Kaeberlein M
    Front Genet; 2015; 6():247. PubMed ID: 26257774
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Post onset, oral rapamycin treatment delays development of mitochondrial encephalopathy only at supramaximal doses.
    Felici R; Buonvicino D; Muzzi M; Cavone L; Guasti D; Lapucci A; Pratesi S; De Cesaris F; Luceri F; Chiarugi A
    Neuropharmacology; 2017 May; 117():74-84. PubMed ID: 28161373
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Acarbose suppresses symptoms of mitochondrial disease in a mouse model of Leigh syndrome.
    Bitto A; Grillo AS; Ito TK; Stanaway IB; Nguyen BMG; Ying K; Tung H; Smith K; Tran N; Velikanje G; Urfer SR; Snyder JM; Barton J; Sharma A; Kayser EB; Wang L; Smith DL; Thompson JW; DuBois L; DePaolo W; Kaeberlein M
    Nat Metab; 2023 Jun; 5(6):955-967. PubMed ID: 37365290
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regional metabolic signatures in the Ndufs4(KO) mouse brain implicate defective glutamate/α-ketoglutarate metabolism in mitochondrial disease.
    Johnson SC; Kayser EB; Bornstein R; Stokes J; Bitto A; Park KY; Pan A; Sun G; Raftery D; Kaeberlein M; Sedensky MM; Morgan PG
    Mol Genet Metab; 2020 Jun; 130(2):118-132. PubMed ID: 32331968
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mitochondrial complex I deficiency leads to the retardation of early embryonic development in
    Wang M; Huang YP; Wu H; Song K; Wan C; Chi AN; Xiao YM; Zhao XY
    PeerJ; 2017; 5():e3339. PubMed ID: 28533980
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genetic reduction of mitochondrial complex I function does not lead to loss of dopamine neurons in vivo.
    Kim HW; Choi WS; Sorscher N; Park HJ; Tronche F; Palmiter RD; Xia Z
    Neurobiol Aging; 2015 Sep; 36(9):2617-27. PubMed ID: 26070241
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of Chronic Administration of Low Dose Rapamycin on Development and Immunity in Young Rats.
    Lu Z; Liu F; Chen L; Zhang H; Ding Y; Liu J; Wong M; Zeng LH
    PLoS One; 2015; 10(8):e0135256. PubMed ID: 26248290
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gait analysis in a mouse model resembling Leigh disease.
    de Haas R; Russel FG; Smeitink JA
    Behav Brain Res; 2016 Jan; 296():191-198. PubMed ID: 26363424
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chronic oral rapamycin decreases adiposity, hepatic triglycerides and insulin resistance in male mice fed a diet high in sucrose and saturated fat.
    den Hartigh LJ; Goodspeed L; Wang SA; Kenerson HL; Omer M; O'Brien KD; Ladiges W; Yeung R; Subramanian S
    Exp Physiol; 2018 Nov; 103(11):1469-1480. PubMed ID: 30117227
    [TBL] [Abstract][Full Text] [Related]  

  • 10. mTOR inhibition suppresses established epilepsy in a mouse model of cortical dysplasia.
    Nguyen LH; Brewster AL; Clark ME; Regnier-Golanov A; Sunnen CN; Patil VV; D'Arcangelo G; Anderson AE
    Epilepsia; 2015 Apr; 56(4):636-46. PubMed ID: 25752454
    [TBL] [Abstract][Full Text] [Related]  

  • 11. NTP Toxicology and Carcinogenesis Studies of Theophylline (CAS No. 58-55-9) in F344/N Rats and B6C3F1 Mice (Feed and Gavage Studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 1998 Aug; 473():1-326. PubMed ID: 12571677
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Moxibustion at acpoints of governor vessel on regulating PI3K/Akt/mTOR signaling pathway and enhancing autophagy process in APP/PS1 double-transgenic Alzheimer's disease mice].
    Zhang LD; Han W; Zhu CF; Song XG; Cheng H; Yang K; Qin XF; Zhang JY; Gui L
    Zhongguo Zhen Jiu; 2019 Dec; 39(12):1313-8. PubMed ID: 31820607
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mammalian Target of Rapamycin Inhibition in
    Rojas Márquez JD; Ana Y; Baigorrí RE; Stempin CC; Cerban FM
    Front Immunol; 2018; 9():313. PubMed ID: 29515594
    [TBL] [Abstract][Full Text] [Related]  

  • 14. NTP Toxicology and Carcinogenesis Studies of Benzyl Acetate (CAS No. 140-11-4) in F344/N Rats and B6C3F1 Mice Feed Studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 1993 Sep; 431():1-285. PubMed ID: 12616300
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rapamycin treatment dose-dependently improves the cystic kidney in a new ADPKD mouse model via the mTORC1 and cell-cycle-associated CDK1/cyclin axis.
    Li A; Fan S; Xu Y; Meng J; Shen X; Mao J; Zhang L; Zhang X; Moeckel G; Wu D; Wu G; Liang C
    J Cell Mol Med; 2017 Aug; 21(8):1619-1635. PubMed ID: 28244683
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hepatic S6K1 Partially Regulates Lifespan of Mice with Mitochondrial Complex I Deficiency.
    Ito TK; Lu C; Khan J; Nguyen Q; Huang HZ; Kim D; Phillips J; Tan J; Lee Y; Nguyen T; Khessib S; Lim N; Mekvanich S; Oh J; Pineda VV; Wang W; Bitto A; An JY; Morton JF; Setou M; Ladiges WC; Kaeberlein M
    Front Genet; 2017; 8():113. PubMed ID: 28919908
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Angiotensin II blockade: how its molecular targets may signal to mitochondria and slow aging. Coincidences with calorie restriction and mTOR inhibition.
    de Cavanagh EM; Inserra F; Ferder L
    Am J Physiol Heart Circ Physiol; 2015 Jul; 309(1):H15-44. PubMed ID: 25934099
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long term rapamycin treatment improves mitochondrial DNA quality in aging mice.
    Bielas J; Herbst A; Widjaja K; Hui J; Aiken JM; McKenzie D; Miller RA; Brooks SV; Wanagat J
    Exp Gerontol; 2018 Jun; 106():125-131. PubMed ID: 29486228
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intermittent dosing of rapamycin maintains antiepileptogenic effects in a mouse model of tuberous sclerosis complex.
    Rensing N; Han L; Wong M
    Epilepsia; 2015 Jul; 56(7):1088-97. PubMed ID: 26122303
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Superior cancer preventive efficacy of low versus high dose of mTOR inhibitor in a mouse model of prostate cancer.
    Antoch MP; Wrobel M; Gillard B; Kuropatwinski KK; Toshkov I; Gleiberman AS; Karasik E; Moser MT; Foster BA; Andrianova EL; Chernova OV; Gudkov AV
    Oncotarget; 2020 Apr; 11(15):1373-1387. PubMed ID: 32341756
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.